Hadasit Bio-Holdings Ltd. a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel’s foremost medical research center, today announced that one of its portfolio company’s, BioMarCare, which does cancer diagnostics, received a $1 million strategic investment from Micromedic Ltd. with an option to invest an additional $1 million.
Related posts
Israel Bolstering Young Startups With Angel Investor Fund
November 30, 2023
Israeli Medtech Companies Partner To Develop ‘Artificial Lung’
November 30, 2023
Cyber Startup Chosen To Secure Upcoming Tel Aviv Light Rail Line
November 29, 2023
Platform Battling Lies On Israel Expands Reach With 23 New Languages
November 29, 2023
Facebook comments